Mortality, Readmission Low With COVID-19 Discharge on Home Oxygen
All-cause mortality rate 1.3 percent; 30-day readmission rate 8.5 percent among 621 patients discharged on home oxygen
Pneumonia
Short-Course Antibiotics Noninferior for Pediatric Pneumonia
Short-course antibiotic therapy comparable to standard care for community-acquired pneumonia
Updates to the 2021 Adult Immunization Schedule
The ACIP emphasizes the importance of routine vaccinations during the pandemic to prevent diseases.
Priority Review Granted to Novel Pneumococcal Conjugate Vaccine V114
The V114 vaccine candidate consists of pneumococcal polysaccharides from 15 serotypes, including serotypes 22F and 33F, which are associated with invasive pneumococcal disease.
Case Series Describes Use of Icosapent Ethyl for COVID-19 Pneumonia
The authors described the cases of 3 patients with moderate to severe COVID-19 pneumonia who were treated with 2g of icosapent ethyl administered twice daily via a nasogastric tube.
Priority Review Granted to 20-Valent Pneumococcal Conjugate Vaccine
The 20vPnC vaccine candidate consists of capsular polysaccharide conjugates for the 13 serotypes included in Prevnar 13, along with 7 additional serotypes that cause invasive pneumococcal disease.
Certain HTN Meds May Cut Deaths From Influenza, Pneumonia
Use of ACE-I/ARB vs nonuse linked to lower mortality for those hospitalized with flu, pneumonia.
Novel Pneumococcal Conjugate Vaccine Immunogenic in Phase 3 Trials
Results from PNEU-PATH demonstrated comparable immune responses following vaccination with Pneumovax 23 in both treatment groups for the 15 serotypes in V114.
Fetroja Approved for Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia
The FDA has approved Fetroja® (cefiderocol; Shionogi) for the treatment of adult patients with HABP/VABP caused by susceptible Gram-negative pathogens.
In-Hospital Heart Failure Deaths Down With Routine Vaccinations
Patients with heart failure receiving flu, pneumonia vaccinations have lower in-hospital mortality
